Labeling — Thymomax
Labeling labeling artefact for Thymosilib in Singapore. Version 18.6. Language: en.
Artifact ID
LBL-047
Type
Labeling
Product
Market
Singapore
Version
18.6
Language
en
Status
Active
Last Reviewed
2023-08-31
Included Statements (3)
| ID | Type | Source | Text | Approved |
|---|---|---|---|---|
| STMT-139 | Dosing | SmPC Section 4.1 | Patients should be advised not to drive or operate machinery if they experience … | 2023-05-10 |
| STMT-140 | Special Population | SmPC Section 5.1 | A paediatric investigation plan (PIP) has been agreed with the EMA.… | 2023-08-02 |
| STMT-141 | PK | SmPC Section 4.4 | Renal impairment does not significantly alter the pharmacokinetics of this compo… | 2024-02-19 |
Change History